Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Pain Resulting From Thermal Injury
NCT01053702 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2011-04-19
Summary
This is a randomized, double-blind, placebo-controlled, parallel-group, single-dose study of the efficacy of REGN475 in patients with pain due to thermal injury.
Conditions
- Thermal Injury Pain
Interventions
- DRUG
-
R475
IV
- DRUG
-
Placebo
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Paul Tiseo, PhD · Regeneron Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia
NCT06571448 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Response and Efficacy of GW842166 in Pain
NCT00554762 ·Status: WITHDRAWN ·Phase: PHASE1
-
Exparel as a Nerve Block for Severe Hand Pain
NCT02374320 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Autologous Platelet Rich Plasma on Low Back Pain
NCT02983747 ·Status: UNKNOWN ·Phase: NA
-
A Proof of Concept Study to Investigate the Effect of a New Treatment in Patient With Chronic Pain
NCT02459197 ·Status: COMPLETED ·Phase: NA
-
A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
NCT01087203 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain
NCT01019824 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain
NCT00838799 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-effect of SSR180575 in Diabetic Neuropathy
NCT00502515 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
NCT06980948 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures
NCT00143442 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for Treatment of Pain in Patients With Diabetic Neuropathy.
NCT00785577 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject
NCT02348879 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN)
NCT05357677 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
NCT00507936 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Pain Associated With Fibromyalgia
NCT02146430 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism and Treatment of Sympathetically Maintained Pain
NCT01813149 ·Status: TERMINATED ·Phase: NA
-
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
NCT01079325 ·Status: COMPLETED ·Phase: PHASE2
-
Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers
NCT01981395 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Treatment Option for Neuropathic Pain
NCT02490436 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration
NCT03912220 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain
NCT01920087 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Neuropathic Pain in Patients With Cancer
NCT00474916 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
NCT00476931 ·Status: COMPLETED ·Phase: PHASE2